SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

ANI Pharmaceuticals Q1 Adj. EPS $1.040 Beats $0.890 Estimate, Sales $49.774M Miss $50.230M Estimate

ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $1.040 per share which beat the analyst consensus estimate of $0.890 by 16.85 percent. This is a 20 percent decrease over earnings of $1.300 per share from

Benzinga · 05/07/2020 12:48

ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $1.040 per share which beat the analyst consensus estimate of $0.890 by 16.85 percent. This is a 20 percent decrease over earnings of $1.300 per share from the same period last year. The company reported quarterly sales of $49.774 million which missed the analyst consensus estimate of $50.230 million by 0.91 percent. This is a 5.89 percent decrease over sales of $52.887 million the same period last year.